Casdin Capital, LLC Q1 2023 Filing
Filed May 15, 2023
Portfolio Value
$1.2T
Holdings
40
Report Date
Q1 2023
Filing Type
13F-HR
All Holdings (40 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | BLFSBIOLIFE SOLUTIONS INC | 7,571,535 | $164.7B | 13.57% | |
| 2 | SRPTSAREPTA THERAPEUTICS INC | 1,185,000 | $163.3B | 13.45% | Call |
| 3 | RLAYRELAY THERAPEUTICS INC | 5,698,574 | $93.9B | 7.73% | |
| 4 | —EQRX INC | 39,527,669 | $76.7B | 6.32% | |
| 5 | ILMNILLUMINA INC | 275,000 | $64.0B | 5.27% | |
| 6 | ALNYALNYLAM PHARMACEUTICALS INC | 270,000 | $54.1B | 4.46% | |
| 7 | NTLAINTELLIA THERAPEUTICS INC | 1,275,000 | $47.5B | 3.91% | |
| 8 | PLRXPLIANT THERAPEUTICS INC | 1,675,000 | $44.6B | 3.67% | |
| 9 | RVMDREVOLUTION MEDICINES INC | 1,810,000 | $39.2B | 3.23% | |
| 10 | EXASEXACT SCIENCES CORP | 565,000 | $38.3B | 3.16% | |
| 11 | SMFRUSDGENEDX HOLDINGS CORP | 102,151,785 | $37.3B | 3.07% | |
| 12 | SLGCUSDSOMALOGIC INC | 12,604,275 | $32.1B | 2.65% | |
| 13 | VERVVERVE THERAPEUTICS INC | 2,120,571 | $30.6B | 2.52% | |
| 14 | 2L9BLUEPRINT MEDICINES CORP | 670,000 | $30.1B | 2.48% | |
| 15 | DNLIDENALI THERAPEUTICS INC | 1,300,000 | $30.0B | 2.47% | |
| 16 | MXCTGBXMAXCYTE INC | 4,925,000 | $24.4B | 2.01% | |
| 17 | TSVT*2SEVENTY BIO INC | 2,023,913 | $20.6B | 1.70% | |
| 18 | ABCLABCELLERA BIOLOGICS INC | 2,520,000 | $19.0B | 1.57% | |
| 19 | MRTXEURMIRATI THERAPEUTICS INC | 510,000 | $19.0B | 1.56% | |
| 20 | FDMT4D MOLECULAR THERAPEUTICS IN | 1,070,000 | $18.4B | 1.52% | |
| 21 | BEAMBEAM THERAPEUTICS INC | 570,000 | $17.5B | 1.44% | |
| 22 | TNYATENAYA THERAPEUTICS INC | 6,078,860 | $17.3B | 1.43% | |
| 23 | GPCRSTRUCTURE THERAPEUTICS INC | 677,017 | $16.1B | 1.33% | |
| 24 | —PROMETHEUS BIOSCIENCES INC | 150,000 | $16.1B | 1.33% | |
| 25 | RNAAVIDITY BIOSCIENCES INC | 850,000 | $13.0B | 1.07% | |
| 26 | FATEFATE THERAPEUTICS INC | 2,050,000 | $11.7B | 0.96% | |
| 27 | IPSCCENTURY THERAPEUTICS INC | 3,206,380 | $11.1B | 0.92% | |
| 28 | TWSTTWIST BIOSCIENCE CORP | 700,000 | $10.6B | 0.87% | |
| 29 | ABSIABSCI CORPORATION | 5,393,260 | $9.4B | 0.78% | |
| 30 | PRMEPRIME MEDICINE INC | 734,350 | $9.0B | 0.74% | |
| 31 | —DICE THERAPEUTICS INC | 310,000 | $8.9B | 0.73% | |
| 32 | OPRXOPTIMIZERX CORP | 500,000 | $7.3B | 0.60% | |
| 33 | INCYINCYTE CORP | 77,500 | $5.6B | 0.46% | |
| 34 | GLUEMONTE ROSA THERAPEUTICS INC | 510,882 | $4.0B | 0.33% | |
| 35 | TNGXTANGO THERAPEUTICS INC | 1,000,000 | $4.0B | 0.33% | |
| 36 | —SINGULAR GENOMICS SYSTEMS IN | 1,345,722 | $1.6B | 0.13% | |
| 37 | NVTA1EURINVITAE CORP | 1,038,388 | $1.4B | 0.12% | |
| 38 | EXAIEUREXSCIENTIA PLC | 213,900 | $1.1B | 0.09% | |
| 39 | LIANYLIANBIO | 206,415 | $402.5M | 0.03% | |
| 40 | KRON1USDKRONOS BIO INC | 123,839 | $180.8M | 0.01% |